A probiotic, Lacticaseibacillus rhamnosus HA-114, was found to prevent neurodegeneration as a neuro protective agent in a C. elegans worm animal model. The research team is currently confirming their findings with similar tests of mice.
The December 20 2022 Neuroscience News report was conducted by Canada’s CHUM Research Center (CRCHUM) led by Université de Montréal neuroscience professor Alex Parker. Parker collaborated with Martine Tétreault and Matthieu Ruiz, researchers at the Montreal Heart Institute Research Center.
Parker and his team found that this probiotic disrupts lipid metabolism which contributes to cerebral and motor degeneration in ALS patients. He further explains that “gut microbiota is likely involved in the onset and progression of many incurable neurodegenerative diseases, including ALS” and Huntington’s disease, as quoted in the Neuroscience News article.
More studies are being conducted today on mice based on this research using the C. elegans worm.